Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 7
2002 2
2003 6
2004 10
2005 10
2006 14
2007 9
2008 14
2009 9
2010 9
2011 5
2012 2
2013 10
2014 6
2015 4
2016 5
2017 5
2018 5
2019 5
2020 6
2022 1
2023 2
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of efficacy, safety, and cost-effectiveness of montelukast-levocetirizine and montelukast-fexofenadine in patients of allergic rhinitis: A randomized, double-blind clinical trial.
Mahatme MS, Dakhale GN, Tadke K, Hiware SK, Dudhgaonkar SD, Wankhede S. Mahatme MS, et al. Indian J Pharmacol. 2016 Nov-Dec;48(6):649-653. doi: 10.4103/0253-7613.194854. Indian J Pharmacol. 2016. PMID: 28066101 Free PMC article. Clinical Trial.
The patients were randomly divided into two treatment groups with montelukast-levocetirizine (10 mg and 5 mg) in one group and montelukast-fexofenadine (10 mg and 120 mg) in another group. ...The cost-effectiveness ratio was less in montelukast-levocetirizine group …
The patients were randomly divided into two treatment groups with montelukast-levocetirizine (10 mg and 5 mg) in one group and montel …
Beneficial effect of nasal saline irrigation in children with allergic rhinitis and asthma: A randomized clinical trial.
Jung M, Lee JY, Ryu G, Lee KE, Hong SD, Choi J, Kim S, Ahn K, Dhong HJ, Chung SK, Kim J, Kim HY. Jung M, et al. Asian Pac J Allergy Immunol. 2020 Dec;38(4):251-257. doi: 10.12932/AP-070918-0403. Asian Pac J Allergy Immunol. 2020. PMID: 31012599 Free article. Clinical Trial.
All patients received 12-week treatment with montelukast, levocetirizine, and inhaled glucocorticoids. Provocative concentrations of methacholine causing a 20% decrease in FEV1 (PC20), Asthma Control Test (ACT), the Questionnaire for Quality-of-Life Specific to Allergic Rh …
All patients received 12-week treatment with montelukast, levocetirizine, and inhaled glucocorticoids. Provocative concentrations of …
Efficacy and safety of bilastine vs. levocetirizine for the treatment of chronic idiopathic urticaria: A multicenter, double-blind, double-dummy, phase III, non-inferiority, randomized clinical trial.
Chen X, Han X, Cheng B, Li H, Liu L, Geng S, Li L, Li J, Guo Q, Zhang G, Fang H, Zhang J. Chen X, et al. Chin Med J (Engl). 2024 Jun 20;137(12):1480-1482. doi: 10.1097/CM9.0000000000003071. Epub 2024 Apr 1. Chin Med J (Engl). 2024. PMID: 38557589 Free PMC article. Clinical Trial. No abstract available.
Assessment of the effects of antihistamine drugs on mood, sleep quality, sleepiness, and dream anxiety.
Ozdemir PG, Karadag AS, Selvi Y, Boysan M, Bilgili SG, Aydin A, Onder S. Ozdemir PG, et al. Int J Psychiatry Clin Pract. 2014 Aug;18(3):161-8. doi: 10.3109/13651501.2014.907919. Epub 2014 Apr 23. Int J Psychiatry Clin Pract. 2014. PMID: 24673474 Clinical Trial.
RESULTS: Outpatients who received cetirizine and hydroxyzine treatments reported higher scores on the depression, anxiety, and fatigue sub-scales than those who received desloratadine, levocetirizine, and rupatadine. Pheniramine and rupatadine were found to be associated w …
RESULTS: Outpatients who received cetirizine and hydroxyzine treatments reported higher scores on the depression, anxiety, and fatigue sub-s …
Levocetirizine and Prednisone Are Not Superior to Levocetirizine Alone for the Treatment of Acute Urticaria: A Randomized Double-Blind Clinical Trial.
Barniol C, Dehours E, Mallet J, Houze-Cerfon CH, Lauque D, Charpentier S. Barniol C, et al. Ann Emerg Med. 2018 Jan;71(1):125-131.e1. doi: 10.1016/j.annemergmed.2017.03.006. Epub 2017 May 3. Ann Emerg Med. 2018. PMID: 28476259 Clinical Trial.
Patients with anaphylaxis or who had received antihistamines or glucocorticoids during the previous 5 days were not included. In addition to levocetirizine (5 mg orally for 5 days), patients were assigned to receive prednisone (40 mg orally for 4 days) or placebo. ...CONCL …
Patients with anaphylaxis or who had received antihistamines or glucocorticoids during the previous 5 days were not included. In addition to …
Clinical assessment of levocetirizine and budesonide in treatment of persistent allergic rhinitis regarding to symptom severity.
Kulapaditharom B, Pornprasertsuk K, Boonkitticharoen V. Kulapaditharom B, et al. J Med Assoc Thai. 2010 Feb;93(2):215-23. J Med Assoc Thai. 2010. PMID: 20302004 Clinical Trial.

OBJECTIVE: To compare effectiveness of levocetirizine and budesonide in treatment of persistent allergic rhinitis (PER) in patients with high and low total symptom scores (TSS). ...Budesonide was more effective against high than low symptoms (p < 0.001) but showed no di

OBJECTIVE: To compare effectiveness of levocetirizine and budesonide in treatment of persistent allergic rhinitis (PER) in patients w …
Comparative clinical efficacy, onset and duration of action of levocetirizine and desloratadine for symptoms of seasonal allergic rhinitis in subjects evaluated in the Environmental Exposure Unit (EEU).
Day JH, Briscoe MP, Rafeiro E, Ratz JD. Day JH, et al. Int J Clin Pract. 2004 Feb;58(2):109-18. doi: 10.1111/j.1368-5031.2004.0117.x. Int J Clin Pract. 2004. PMID: 15055856 Clinical Trial.
Levocetirizine acted earlier (1 h vs. 3 h) and produced greater symptom relief at 24 h than desloratadine (p = 0.003). ...Levocetirizine and desloratadine were safe and well tolerated....
Levocetirizine acted earlier (1 h vs. 3 h) and produced greater symptom relief at 24 h than desloratadine (p = 0.003). ...Levoceti
Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trial.
Potter PC; Paediatric Levocetirizine Study Group. Potter PC, et al. Ann Allergy Asthma Immunol. 2005 Aug;95(2):175-80. doi: 10.1016/S1081-1206(10)61208-2. Ann Allergy Asthma Immunol. 2005. PMID: 16136768 Clinical Trial.
The 50% response rate for the first 2 weeks was 12.3% for the levocetirizine group compared with 3.9% for the placebo group (P = .01). The investigators' global evaluation also favored levocetirizine, because 57.1% of the children in the levocetirizine group …
The 50% response rate for the first 2 weeks was 12.3% for the levocetirizine group compared with 3.9% for the placebo group (P = .01) …
Comparison of the sedating effects of levocetirizine and cetirizine: a randomized, double-blind, placebo-controlled trial.
Tzanetos DB, Fahrenholz JM, Scott T, Buchholz K. Tzanetos DB, et al. Ann Allergy Asthma Immunol. 2011 Dec;107(6):517-22. doi: 10.1016/j.anai.2011.08.012. Epub 2011 Sep 19. Ann Allergy Asthma Immunol. 2011. PMID: 22123381 Clinical Trial.
BACKGROUND: Compared with placebo, levocetirizine has been found to be less sedating than cetirizine in separate trials. However, whether levocetirizine is less sedating than its parent drug cetirizine has not yet been studied in a randomized trial. ...RESULTS: Seda …
BACKGROUND: Compared with placebo, levocetirizine has been found to be less sedating than cetirizine in separate trials. However, whe …
Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial.
de Blic J, Wahn U, Billard E, Alt R, Pujazon MC. de Blic J, et al. Pediatr Allergy Immunol. 2005 May;16(3):267-75. doi: 10.1111/j.1399-3038.2005.00216.x. Pediatr Allergy Immunol. 2005. PMID: 15853959 Clinical Trial.
The effect of levocetirizine was almost twice that of placebo (94.1% relative improvement over placebo). ...Incidence of treatment-emergent adverse events was similar in both groups (33.7% with levocetirizine; 30.7% with placebo). No child in the levocetirizine
The effect of levocetirizine was almost twice that of placebo (94.1% relative improvement over placebo). ...Incidence of treatment-em …
134 results